研究报告 |
|
|
|
|
S100A9参与乙型肝炎病毒X蛋白介导的HepG2细胞增殖与迁移 * |
张秀瑜1,王玎1,杜燕娥1,武睿2,段亮1,**() |
1 重庆医科大学附属第二医院 重庆 400016 2 重庆医科大学附属第一医院 重庆 400016 |
|
S100A9 is Involved in Hepatitis B Virus X-induced Proliferation and Migration of Human Hepatocellular Carcinoma Cell HepG2 |
Xiu-yu ZHANG1,Ding WANG1,Yan-e DU1,Rui WU2,Liang DUAN1,**() |
1 The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China 2 The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China |
引用本文:
张秀瑜,王玎,杜燕娥,武睿,段亮. S100A9参与乙型肝炎病毒X蛋白介导的HepG2细胞增殖与迁移 *[J]. 中国生物工程杂志, 2018, 38(10): 1-7.
Xiu-yu ZHANG,Ding WANG,Yan-e DU,Rui WU,Liang DUAN. S100A9 is Involved in Hepatitis B Virus X-induced Proliferation and Migration of Human Hepatocellular Carcinoma Cell HepG2. China Biotechnology, 2018, 38(10): 1-7.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20181001
或
https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I10/1
|
[1] |
Zhu R X, Seto W K, Lai C L , et al. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver, 2016,10(3):332-339.
doi: 10.5009/gnl15257
pmid: 27114433
|
[2] |
Levrero M, Zucman-Rossi J . Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol, 2016,64(1 Suppl):S84-S101.
doi: 10.1016/j.jhep.2016.02.021
|
[3] |
Seeger C, Mason W S . Molecular biology of hepatitis B virus infection. Virology, 2015, 479-480:672-686.
doi: 10.1016/j.virol.2015.02.031
pmid: 25759099
|
[4] |
Zhang X D, Wang Y, Ye L H . Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med, 2014,11(3):182-190.
doi: 10.7497/j.issn.2095-3941.2014.03.004
pmid: 4197427
|
[5] |
Sung W K, Zheng H, Li S , et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet, 2012,44(7):765-769.
doi: 10.1038/ng.2295
pmid: 22634754
|
[6] |
Bianchi M E . DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol, 2007,81(1):1-5.
doi: 10.1189/jlb.0306164
pmid: 17032697
|
[7] |
Chen H, Xu C, Jin Q , et al. S100 protein family in human cancer. AM J Cancer Res, 2014,4(2):89-115.
doi: 10.3901/JME.2014.16.089
pmid: 3960449
|
[8] |
Markowitz J , Iii W E C. Review of S100A9 biology and its role in cancer. Biochim Biophys Acta, 2013,1835(1):100-109.
doi: 10.1016/j.bbcan.2012.10.003
pmid: 3670606
|
[9] |
Motavaf M, Safari S, Saffari J M , et al. Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. Acta Virol, 2013,57(4):389-396.
doi: 10.4149/av_2013_04_389
pmid: 24294951
|
[10] |
Zhang T, Zhang J, You X , et al. Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology, 2012,56(6):2051-2059.
doi: 10.1002/hep.25899
pmid: 22707013
|
[11] |
Chen Z, Tang J, Cai X , et al. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway. Cancer Sci, 2016,107(10):1380-1389.
doi: 10.1111/cas.13014
pmid: 27420729
|
[12] |
Chen B, Miller A L, Rebelatto M , et al. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo. PLoS One, 2015,10(2):e0115828.
doi: 10.1371/journal.pone.0115828
pmid: 25706559
|
[13] |
van Lent P L, Grevers L, Blom A B , et al. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis, 2008,67(12):1750-1758.
doi: 10.1136/ard.2007.077800
|
[14] |
Lee M J, Lee J K, Choi J W , et al. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One, 2012,7(9):e38801.
doi: 10.1371/journal.pone.0038801
pmid: 22962574
|
[15] |
Tsai S Y, Seqovia J A, Chang T H , et al. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza a virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PloS Pathog, 2014,10(1):e1003848.
doi: 10.1371/journal.ppat.1003848
pmid: 3879357
|
[16] |
Baines K J, Hsu A C, Tooze M , et al. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res, 2013,14(1):15.
doi: 10.1186/1465-9921-14-15
pmid: 23384071
|
[17] |
Gebhardt C, Nemeth J, Angel P , et al. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol, 2006,72(11):1622-1631.
doi: 10.1016/j.bcp.2006.05.017
pmid: 16846592
|
[18] |
Srikrishna G . S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun, 2012,4(1):31-40.
doi: 10.1159/000330095
|
[19] |
Wu R, Duan L, Cui F , et al. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1 /2 and p38 MAPK pathways. Exp Cell Res, 2015,334(2):228-238.
doi: 10.1016/j.yexcr.2015.04.008
pmid: 25907296
|
[20] |
Hermani A, Hess J, De Servi B , et al. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res, 2005,11(14):5146-5152.
doi: 10.1158/1078-0432.CCR-05-0352
pmid: 16033829
|
[21] |
Kim H J, Kang H J, Lee H , et al. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res, 2009,8(3):1368-1379.
doi: 10.1021/pr8007573
pmid: 19186948
|
[22] |
Nemeth J, Stein I, Haag D , et al. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver arcinogenesis. Hepatology, 2009,50(4):1251-1262.
doi: 10.1002/hep.23099
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|